z-logo
open-access-imgOpen Access
Performing Cytoreductive Nephrectomy following Targeted Sunitinib Therapy for Metastatic Renal Cell Carcinoma: A Surgical Perspective
Author(s) -
Greg Shaw,
Mahreen Hussain,
Rajesh Nair,
John Bycroft,
Luis Beltrán,
James Green,
Thomas Powles,
John L. Peters
Publication year - 2012
Publication title -
urologia internationalis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.771
H-Index - 53
eISSN - 1423-0399
pISSN - 0042-1138
DOI - 10.1159/000338057
Subject(s) - medicine , sunitinib , nephrectomy , renal cell carcinoma , perioperative , surgery , blood loss , urology , neoadjuvant therapy , kidney , cancer , breast cancer
To describe for surgeons contemplating performing cytoreductive nephrectomy (CRN) on patients after neoadjuvant sunitinib compared to a benchmark of open radical nephrectomy, describing technical difficulties, safety and feasibility.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom